The TessArae GeneCipher™ performs Targeted Resequencing with turnaround times and costs that are dramatic improvements over Sanger Sequencing. Array design is done by expert TessArae scientists and our advanced analysis software gives insight into both known and unknown mutations that exist in hundreds of genes in a single assay in days instead of weeks. Whether you're translating discovery results from genome wide studies into clinical applications or performing pathogen detection/identification, TessArae enables you to perform targeted resequencing faster, more easily and less expensively than other methods. (more)

The Benchmark:
Targeted Sequencing

 

  • • Analyze Hundreds of Genes in Single Assay
  • • Comprehensive Mutation Detection
  • • Single Day Turn-Around: Sample to Result
  • • Half the Cost of Sanger Sequencing

Learn More

Microbial Detection:
Move Beyond PCR®

 

  • • Simultaneous Detection and Identification of
  •   Hundreds of Microbial Pathogens
  • • No False Positive Results
  • • Identify Novel & Emerging Pathogens
    Learn More

  March 22, 2012

TessArae to Exhibit at 2012 ACMG Annual Clinical Genetics Meeting

Read More In Our Blog

  October 18, 2011

TessArae CEO Dr. Klaus Schafer to Speak at Annual Wharton Alumni Healthcare Conference

Read More In Our Blog

  June 8, 2011

TessArae, LLC Taps L. Thomas Richards, M.D. as President

Read More In Our Blog